Company profile: Avextra
1.1 - Company Overview
Company description
- Provider of cannabis-based medicines and manufacturing services, controlling the full value chain from cultivation in Portugal to GMP-certified production in Germany. Offers R&D and clinical trials to build evidence, collaborates with healthcare professionals on real-world data and RCTs for regulatory filings, and distributes therapies via agreements in Switzerland and Austria.
Products and services
- Cultivation and Production: Avextra constructs and controls the entire value chain, spanning cannabis cultivation in Portugal to GMP-certified production in Germany
- Cannabis-based Medicines: Avextra produces and distributes standardized cannabis-derived therapeutic products for medical use, supplying medical professionals, patients, and communities with secure, plant-based medicine
- Research and Development: Avextra architects evidence-based research programs to expand the evidence base for therapies using cannabis-based medicines, advancing therapeutic products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avextra
AMP Alternative Medical Products
HQ: Canada
Website
- Description: Provider of medical cannabis distribution and a contemporary medical cannabis and wellness application, selecting and collaborating with cannabis producers and offering therapeutic standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AMP Alternative Medical Products company profile →
Kaya Holdings
HQ: United States
Website
- Description: Provider of cannabis-related products and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kaya Holdings company profile →
BellRock Brands
HQ: United States
Website
- Description: Provider of a multi-state, intellectual property-focused CPG house of cannabis brands offering one of the industry's broadest branded product portfolios. Anchored by Mary's Medicinals and Dixie, with products including therapeutic cannabinoid health and wellness, cannabis-infused edibles and beverages, CBD wellness, hemp pet consumables and topicals, premium single-strain concentrates, and alcohol-free cannabis-infused wine and seltzers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BellRock Brands company profile →
Valens
HQ: Canada
Website
- Description: Provider of cannabinoid-based consumer products through specialized cannabis extraction, testing, analytics, and manufacturing, offering proprietary CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction and analytical testing services to Canadian and international cannabis brands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valens company profile →
American Cannabis Company
HQ: United States
Website
- Description: Provider of industry-specific advisory and consulting for recreational and medical cannabis and commercial hemp, including strategic planning, financial modeling, business planning, conceptual design, and application services; operational and cultivation management; ACC brand licensing; acquisitions and equity partnerships; and manufacturing cultivation products and facilities for startups, serving domestic and international markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full American Cannabis Company company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avextra
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avextra
2.2 - Growth funds investing in similar companies to Avextra
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avextra
4.2 - Public trading comparable groups for Avextra
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →